<?xml version="1.0" encoding="UTF-8"?>
<p>Studies describing the mechanisms of action of NS1 during viral infection have been primarily focused in IAV (
 <xref rid="B26" ref-type="bibr">Garcia-Sastre et al., 1998</xref>; 
 <xref rid="B64" ref-type="bibr">Nemeroff et al., 1998</xref>; 
 <xref rid="B20" ref-type="bibr">Falcon et al., 1999</xref>; 
 <xref rid="B8" ref-type="bibr">Burgui et al., 2003</xref>; 
 <xref rid="B107" ref-type="bibr">Twu et al., 2006</xref>; 
 <xref rid="B29" ref-type="bibr">Guo et al., 2007</xref>; 
 <xref rid="B40" ref-type="bibr">Kochs et al., 2007</xref>, 
 <xref rid="B41" ref-type="bibr">2009</xref>; 
 <xref rid="B54" ref-type="bibr">Mibayashi et al., 2007</xref>; 
 <xref rid="B31" ref-type="bibr">Hale et al., 2008a</xref>, 
 <xref rid="B32" ref-type="bibr">b</xref>, 
 <xref rid="B33" ref-type="bibr">2010</xref>; 
 <xref rid="B100" ref-type="bibr">Steidle et al., 2010</xref>; 
 <xref rid="B16" ref-type="bibr">Dankar et al., 2013</xref>; 
 <xref rid="B3" ref-type="bibr">Ayllon et al., 2014</xref>; 
 <xref rid="B18" ref-type="bibr">DeDiego et al., 2016</xref>; 
 <xref rid="B72" ref-type="bibr">Nogales et al., 2016b</xref>, 
 <xref rid="B67" ref-type="bibr">2017a</xref>,
 <xref rid="B70" ref-type="bibr">d</xref>, 
 <xref rid="B74" ref-type="bibr">2018a</xref>,
 <xref rid="B75" ref-type="bibr">b</xref>; 
 <xref rid="B11" ref-type="bibr">Chauche et al., 2018</xref>; 
 <xref rid="B94" ref-type="bibr">Rodriguez et al., 2018</xref>), IBV (
 <xref rid="B116" ref-type="bibr">Yuan and Krug, 2001</xref>; 
 <xref rid="B17" ref-type="bibr">Dauber et al., 2006</xref>; 
 <xref rid="B30" ref-type="bibr">Hai et al., 2008</xref>; 
 <xref rid="B77" ref-type="bibr">Nogales et al., 2015</xref>; 
 <xref rid="B83" ref-type="bibr">Patzina et al., 2017</xref>) and, to a less extent, ICV (
 <xref rid="B61" ref-type="bibr">Nakada et al., 1986</xref>; 
 <xref rid="B60" ref-type="bibr">Muraki et al., 2010</xref>; 
 <xref rid="B80" ref-type="bibr">Pachler and Vlasak, 2011</xref>). Nothing is currently known about the ability of IDV NS1 to counteract the IFN response. Moreover, it is unclear whether the NS1 proteins of IBV, ICV, or IDV have similar properties and/or mechanisms of anti-IFN activity than those of IAV NS1. Interestingly, the NS1 protein from an IAV-like virus of bat origin has been shown to also counteract the IFN system, but does not fully complement replication of IAV in mice when replacing the NS1 from a conventional IAV (
 <xref rid="B105" ref-type="bibr">Turkington et al., 2015</xref>, 
 <xref rid="B106" ref-type="bibr">2018</xref>; 
 <xref rid="B2" ref-type="bibr">Aydillo et al., 2018</xref>). In a recent study, a panel of recombinant viruses expressing different NS1 from human and avian origin were generated, showing that viruses encoding NS1 from human IAV induced higher levels of IFN in human dendritic cells than viruses expressing avian IAV NS1 proteins (
 <xref rid="B55" ref-type="bibr">Monteagudo et al., 2019</xref>). Therefore, there are several functional characteristics of influenza NS1 that remains elusive.
</p>
